LEK-8829

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameLEK-8829
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonistsDopamine D2 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonists +[4] 
TargetsSerotonin 2 (5-HT2) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor +[4] 
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySlovenia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLek Pharmaceutical And Chemical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLek Pharmaceutical And Chemical
Active IndicationsN/A
Inactive IndicationsPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A